Showing 20 of 24 recruiting trials for “primary-mediastinal-large-b-cell-lymphoma”
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Sep 2025View details ↗
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
👨⚕️ Liang Huang, MD, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT07198230 ↗
Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
👨⚕️ Amanda F Cashen, M.D., Washington University School of Medicine📍 1 site📅 Started Jan 2025View details ↗
Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma
👨⚕️ Mariana Bastos-Oreiro, Hospital General Universitario Gregorio Marañón📍 15 sites📅 Started Nov 2024View details ↗
Pola-ZR2P in Previously Untreated DLBCL
Emapalumab Prevention of CAR-T Cell Associated Toxicities
The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
RecruitingNCT06755775 ↗
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Pembro Plus CAR T-cell Therapy in R/R in PMBCL
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingNCT05725720 ↗
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
👨⚕️ Caspian Oliai, MD, UCLA / Jonsson Comprehensive Cancer Center📍 3 sites📅 Started Jan 2023View details ↗
Pro-miniCHOP-like Regimen for Treatment-naive Elderly Patients
RecruitingNCT05377307 ↗
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →